155 results on '"Benson, Don M"'
Search Results
2. Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up
3. T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma
4. Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation
5. BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma
6. Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function
7. A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma
8. Interferon-γ Promotes Antibody-mediated Fratricide of Acute Myeloid Leukemia Cells
9. Granulocyte Colony-Stimulating Factor–Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease
10. Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
11. The Transcription Factor AHR Prevents the Differentiation of a Stage 3 Innate Lymphoid Cell Subset to Natural Killer Cells
12. Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma
13. A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL)
14. Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
15. MicroRNAs activate natural killer cells through Toll-like receptor signaling
16. Final Results from the First-in-Human Phase 1/2 Study of Modakafusp Alfa, an Immune-Targeting Attenuated Cytokine, in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
17. A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
18. The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody
19. CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody
20. Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells
21. 466 - Impact of Opioid Use after Blood and Marrow Transplantation (BMT): A Single-Center Analysis
22. Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells
23. Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies
24. Allogeneic Stem Cell Transplantation for Patients with Relapsed Chemorefractory Aggressive Non-Hodgkin Lymphomas
25. Hlx homeobox transcription factor negatively regulates interferon-γ production in monokine-activated natural killer cells
26. Pro- and Antiinflammatory Cytokine Signaling: Reciprocal Antagonism Regulates Interferon-gamma Production by Human Natural Killer Cells
27. Chunking, rule learning, and multiple item memory in rat interleaved serial pattern learning
28. T-Cell Senescence and Exhaustion Are Associated with Interval Progression of Multiple Myeloma before Autologous Hematopoietic Cell Transplant
29. Multiple Myeloma Transplant: Examining the Intersection of Access, Age and Race
30. Preclinical Development of Hosu-53, a Novel Potent Dihydroorotate Dehydrogenase Inhibitor with Impressive Single Agent Efficacy and Combination Approaches in Hematological Malignancy
31. The Co-Occurrence of 1q21+/1q23+ and t(4;14) Abnormalities with Specific Clone Size Is Predictive of Shorter Response to Transplant in Patients with Multiple Myeloma
32. Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
33. Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
34. Chapter 22 - Natural Killer Cell Immunity
35. 142 - Allogenic Transplantation in Older Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
36. Interval Progression Serves As a Predictor of Adverse Outcomes in Patients with Multiple Myeloma
37. Effect of Age on Outcomes of Allogeneic Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
38. Early Versus Late Discontinuation of Maintenance Therapy in Multiple Myeloma
39. Targeting the Mitotic Checkpoint in Myeloma with OSU-13, a Novel Mps1/Ttk Inhibitor
40. Survival Analysis of Patients with T-Cell Lymphoma or T-Cell Large Granular Leukemia and Concomitant Plasma Cell Dyscrasias
41. CD56 Has a Critical Role in Regulating Multiple Myeloma Cell Growth and Response to Therapies
42. 541 - Geriatric Assessment with Management Highlights Importance of Nutrition in Older Adult Transplant Recipients
43. 540 - Increasing Number of Geriatric Assessment-Identified Deficits Associated with Non-Receipt of Transplant Among Older Adults
44. 504 - Outcomes of Patients after Allogeneic Transplant for Multiple Myeloma – a Single Center Retrospective Analysis
45. 371 - Outcomes in Allogeneic Transplant Based on Race and Geographic Location of Residence
46. 336 - Impact of Chronic Graft-Versus-Host Disease on Non-Relapse Mortality and Survival
47. 282 - Impact of Bone Marrow Versus Peripheral Blood on Outcomes in Haploidentical Transplantation
48. 166 - Trends in Survival of AML and MDS Patients Following Allogeneic Transplant
49. 161 - Longitudinal Survival Outcomes in Allogeneic Stem Cell Transplantation: An Institutional Experience
50. RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.